Market revenue in 2023 | USD 0.7 million |
Market revenue in 2030 | USD 1.6 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 57.14% in 2023. Horizon Databook has segmented the Saudi Arabia 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia is pivotal in the Gulf Cooperation Council (GCC) countries' healthcare expenditures, contributing 60% of the total healthcare spending in the council. This highlights the commitment of the Saudi Arabian government to prioritize healthcare.
The core tenets of these transformative reforms revolve around enhancing the accessibility of healthcare services, expanding the deployment of e-health services & digital solutions, and elevating the overall quality of healthcare offerings.
The specific objectives for enhancing service quality and accessibility will center on optimizing coverage, including geographic expansion, facilitated by the increased utilization of e-health services & digital solutions. In addition to these healthcare advancements, Saudi Arabia is actively exploring the growing 3D printed drugs market and promoting growth & innovation.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account